CLIRNET

CLIRNET Founded in 2015, we empower 650,000+ HCPs globally with Real-World Evidence (RWE)-driven insights.

Our diverse 250+ team (65% women) drives MedWiki®, a platform with 1M+ clinical content pieces, fostering inclusivity and innovation. CLIRNet is creating a network of Indian Physicians who often lack basic infrastructure by meeting their needs on the ground, thereby making it the go-to platform for healthcare companies to market their products and services in an ethical, impactful, and cost-effective manner. CLIRNET enables physicians to expand their reach across the community, add variety in process of information exchange, and most importantly bridge the knowledge divide to enable seamless and quality delivery of patient care across India.

⚕️ FDA Approval | AML ⁣• 𝐙𝐢𝐟𝐭𝐨𝐦𝐞𝐧𝐢𝐛 approved for adults with 𝐫𝐞𝐥𝐚𝐩𝐬𝐞𝐝 𝐨𝐫 𝐫𝐞𝐟𝐫𝐚𝐜𝐭𝐨𝐫𝐲 (𝐑/𝐑) 𝐚𝐜𝐮𝐭𝐞 𝐦𝐲𝐞𝐥𝐨𝐢𝐝 𝐥𝐞𝐮𝐤𝐞𝐦𝐢𝐚 (𝐀𝐌𝐋) c...
22/12/2025

⚕️ FDA Approval | AML ⁣

• 𝐙𝐢𝐟𝐭𝐨𝐦𝐞𝐧𝐢𝐛 approved for adults with 𝐫𝐞𝐥𝐚𝐩𝐬𝐞𝐝 𝐨𝐫 𝐫𝐞𝐟𝐫𝐚𝐜𝐭𝐨𝐫𝐲 (𝐑/𝐑) 𝐚𝐜𝐮𝐭𝐞 𝐦𝐲𝐞𝐥𝐨𝐢𝐝 𝐥𝐞𝐮𝐤𝐞𝐦𝐢𝐚 (𝐀𝐌𝐋) carrying 𝐧𝐮𝐜𝐥𝐞𝐨𝐩𝐡𝐨𝐬𝐦𝐢𝐧-𝟏 (𝐍𝐏𝐌𝟏) mutations. ⁣

• Demonstrated 𝐦𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐫𝐞𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐫𝐚𝐭𝐞𝐬 and 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐭𝐫𝐚𝐧𝐬𝐟𝐮𝐬𝐢𝐨𝐧 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 ⁣
• Represents a targeted advance for patients with limited therapeutic options ⁣

A notable step forward in precision treatment for AML. ⁣

Global Digital CME • Critical Care 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐑𝐞𝐬𝐮𝐬𝐜𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐃𝐞-𝐑𝐞𝐬𝐮𝐬𝐜𝐢𝐭𝐚𝐭𝐢𝐨𝐧: Evolving concepts in Critical Care  🎙...
20/12/2025

Global Digital CME • Critical Care
𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐑𝐞𝐬𝐮𝐬𝐜𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐃𝐞-𝐑𝐞𝐬𝐮𝐬𝐜𝐢𝐭𝐚𝐭𝐢𝐨𝐧:
Evolving concepts in Critical Care

🎙️ Dr. Azza Elmandouh
🗓️ 21 December 2025
⏰ 5:30–6:00 PM EEST | 9:00–9:30 PM IST

Book your seat: https://lnkd.in/gtWFCms2


Does repeat influenza vaccination influence protection? Swipe to know →
19/12/2025

Does repeat influenza vaccination influence protection?

Swipe to know →


𝐏𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐯𝐬 𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 A practical, evidence-based session by Dr.Hussam Eldin Hasan on clinical indications...
18/12/2025

𝐏𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐯𝐬 𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬

A practical, evidence-based session by Dr.Hussam Eldin Hasan on clinical indications, risk–benefit analysis, and access-related considerations.

19 December 2025 | 5:30-6:00 PM AST | 8:00-8:30 PM IST
RSVP: https://lnkd.in/gj8A62up



Global CME | Women’s Health & Endocrinology 𝐓𝐡𝐲𝐫𝐨𝐢𝐝 𝐚𝐧𝐝 𝐌𝐞𝐧𝐨𝐩𝐚𝐮𝐬𝐞 Join Prof. Dr. Prof. Panayoti Bachkangi [Consultant Ob...
17/12/2025

Global CME | Women’s Health & Endocrinology
𝐓𝐡𝐲𝐫𝐨𝐢𝐝 𝐚𝐧𝐝 𝐌𝐞𝐧𝐨𝐩𝐚𝐮𝐬𝐞

Join Prof. Dr. Prof. Panayoti Bachkangi

[Consultant Obstetrician & Urogynaecologist | Menopause Specialist, Lothian Hospital]

🗓 20th December 2025
🕒 4:30–5:00 PM GMT | 10:00–10:30 PM IST

RSVP: https://doctor.clirnet.com/sessions/detail/23004


🚨 Global CME Alert | 17th December 2025 ⁣⁣⁣⁣𝐏𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐇𝐲𝐩𝐞𝐫𝐭𝐞𝐧𝐬𝐢𝐨𝐧 𝐢𝐧 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞  ⁣⁣⁣⁣Join this expert-led session wi...
16/12/2025

🚨 Global CME Alert | 17th December 2025 ⁣⁣
⁣⁣𝐏𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐇𝐲𝐩𝐞𝐫𝐭𝐞𝐧𝐬𝐢𝐨𝐧 𝐢𝐧 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 ⁣⁣
⁣⁣
Join this expert-led session with Dr. Rana Elhelf, MD ⁣⁣
⁣⁣[Cardiology Lecturer, Mansoura University Internal Medicine Hospital] ⁣⁣
⁣⁣
🕒 6:30–7:00 PM EEST | 10:00–10:30 PM IST ⁣⁣
⁣⁣
Register Here: https://doctor.clirnet.com/sessions/detail/22934 ⁣⁣
⁣⁣
⁣⁣

Global Digital CME Alert! 𝐏𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬 Differentiating Viral and Bacterial Aetiologies in Febrile Children  👩...
15/12/2025

Global Digital CME Alert!

𝐏𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬
Differentiating Viral and Bacterial Aetiologies in Febrile Children

👩‍⚕️ Dr. Wafaa Abougabal
MD Paediatrics, Head of Department, Ministry of Health & Population, Egypt

𝟏𝟔𝐭𝐡 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫, 𝟐𝟎𝟐𝟓 | 𝟓:𝟑𝟎–𝟔:𝟎𝟎 𝐏𝐌 𝐄𝐄𝐒𝐓, 𝟗:𝟎𝟎–𝟗:𝟑𝟎 𝐏𝐌 𝐈𝐒𝐓

Book your seat: https://lnkd.in/gv6zedVE


Global-Digital CME  Join 𝐃𝐫. 𝐀𝐡𝐦𝐞𝐝 𝐇𝐚𝐰𝐚𝐬𝐡 as he breaks down 𝐓𝐡𝐞 𝐇𝐚𝐰𝐚𝐬𝐡 𝐌𝐞𝐭𝐡𝐨𝐝, a step-by-step framework for safe AI use ...
13/12/2025

Global-Digital CME

Join 𝐃𝐫. 𝐀𝐡𝐦𝐞𝐝 𝐇𝐚𝐰𝐚𝐬𝐡 as he breaks down 𝐓𝐡𝐞 𝐇𝐚𝐰𝐚𝐬𝐡 𝐌𝐞𝐭𝐡𝐨𝐝, a step-by-step framework for safe AI use in daily clinical practice

📅 14th December, 2025
🕒 7:00 PM – 8:00 PM IST

🔗 Register: https://doctor.clirnet.com/sessions/detail/23069


🚨 𝐂𝐃𝐒𝐂𝐎 Approval Update ⁣ 𝐕𝐨𝐫𝐚𝐬𝐢𝐝𝐞𝐧𝐢𝐛 𝐓𝐚𝐛𝐥𝐞𝐭𝐬 (𝟏𝟎 𝐦𝐠 / 𝟒𝟎 𝐦𝐠) are now approved in India for: ⁣ • Adults and pediatric pa...
12/12/2025

🚨 𝐂𝐃𝐒𝐂𝐎 Approval Update ⁣
𝐕𝐨𝐫𝐚𝐬𝐢𝐝𝐞𝐧𝐢𝐛 𝐓𝐚𝐛𝐥𝐞𝐭𝐬 (𝟏𝟎 𝐦𝐠 / 𝟒𝟎 𝐦𝐠) are now approved in India for: ⁣

• Adults and pediatric patients ≥𝟏𝟐 𝐲𝐞𝐚𝐫𝐬 ⁣
• Grade 2 astrocytoma or oligodendroglioma ⁣
• With IDH1 or IDH2 mutations ⁣
• Post-surgery — biopsy, subtotal resection, or gross total resection ⁣

⁣This marks an important step in expanding targeted therapy options for 𝐥𝐨𝐰-𝐠𝐫𝐚𝐝𝐞 𝐠𝐥𝐢𝐨𝐦𝐚𝐬.

𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐭𝐢𝐧𝐠 𝐕𝐢𝐫𝐚𝐥 & 𝐁𝐚𝐜𝐭𝐞𝐫𝐢𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐬 ⁣ ⁣A focused session by 𝐃𝐫. 𝐁𝐞𝐠𝐚𝐝 𝐌𝐨𝐬𝐭𝐚𝐟𝐚 𝐀𝐥𝐲 𝐖𝐚𝐡𝐛...
11/12/2025

𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐭𝐢𝐧𝐠 𝐕𝐢𝐫𝐚𝐥 & 𝐁𝐚𝐜𝐭𝐞𝐫𝐢𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐬 ⁣

A focused session by 𝐃𝐫. 𝐁𝐞𝐠𝐚𝐝 𝐌𝐨𝐬𝐭𝐚𝐟𝐚 𝐀𝐥𝐲 𝐖𝐚𝐡𝐛𝐚 ⁣
Pulmonology & Tuberculosis Specialist | Former Medical Scientific Liaison (Respiratory & Dermatology) ⁣

𝟏𝟐𝐭𝐡 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟓 | 𝟓:𝟑𝟎–𝟔:𝟎𝟎 𝐏𝐌 𝐄𝐄𝐒𝐓; 𝟗:𝟎𝟎–𝟗:𝟑𝟎 𝐏𝐌 𝐈𝐒𝐓 ⁣

Register Now: https://lnkd.in/gmETUD7P

Global-Digital CME | Severe Head Injury in the ED  Join Dr. Ogechi Nzeoma for a focused session on "𝐎𝐩𝐭𝐢𝐦𝐢𝐬𝐢𝐧𝐠 𝐂𝐚𝐫𝐞 𝐟𝐨𝐫 ...
10/12/2025

Global-Digital CME | Severe Head Injury in the ED

Join Dr. Ogechi Nzeoma for a focused session on "𝐎𝐩𝐭𝐢𝐦𝐢𝐬𝐢𝐧𝐠 𝐂𝐚𝐫𝐞 𝐟𝐨𝐫 𝐒𝐞𝐯𝐞𝐫𝐞 𝐇𝐞𝐚𝐝 𝐈𝐧𝐣𝐮𝐫𝐲 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐄𝐦𝐞𝐫𝐠𝐞𝐧𝐜𝐲 𝐃𝐞𝐩𝐚𝐫𝐭𝐦𝐞𝐧𝐭"

11th December 2025
6:30 PM – 7:00 PM AST | 9:00 PM – 9:30 PM IST

👉 Register Now: https://lnkd.in/g4PKmmRW

𝐅𝐃𝐀 𝐔𝐩𝐝𝐚𝐭𝐞 Mitochondrial Disorders ⁣ New approvals: 𝐃𝐨𝐱𝐞𝐜𝐢𝐭𝐢𝐧𝐞 and 𝐃𝐨𝐱𝐫𝐢𝐛𝐭𝐢𝐦𝐢𝐧𝐞 for 𝐓𝐊𝟐 𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 (𝐓𝐊𝟐𝐝) — a rare mitoc...
09/12/2025

𝐅𝐃𝐀 𝐔𝐩𝐝𝐚𝐭𝐞 Mitochondrial Disorders ⁣

New approvals: 𝐃𝐨𝐱𝐞𝐜𝐢𝐭𝐢𝐧𝐞 and 𝐃𝐨𝐱𝐫𝐢𝐛𝐭𝐢𝐦𝐢𝐧𝐞 for 𝐓𝐊𝟐 𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 (𝐓𝐊𝟐𝐝) — a rare mitochondrial DNA disorder leading to progressive muscle weakness and respiratory failure. ⁣

💡 Why it matters: ⁣

• First therapy for TK2d ⁣
• Granted Breakthrough Therapy Designation ⁣ • Significantly improved survival and reduced mortality ⁣
• Major advance for patients with mitochondrial depletion ⁣

Address

264-265, Drive Annie Besant Rd
Mumbai
400025

Opening Hours

Monday 10am - 6:30pm
Tuesday 10am - 6:30pm
Wednesday 10am - 6:30pm
Thursday 10am - 6:30pm
Friday 10am - 6:30pm
Saturday 10am - 6:30pm

Telephone

+918335822001

Alerts

Be the first to know and let us send you an email when CLIRNET posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CLIRNET:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

The Unusual Discovery!

CLIRNet is a unique platform connecting doctors with different specializations across India and abroad. CLIRNet offers one-on-one interaction with doctors and it’s embarking on the Era of Digital Health to improve patient care. CLIRNet offers access to Evidence-Based Medical Discussions on various specialties in an easily searchable format.

CLIRNet was nominated in the prestigious Times Network Digital Summit for Digital Social Innovation.

The support for healthcare is growing and CLIRNet being the only doctor’s app is changing ways for patient care and updating them. CLIRNet is improving healthcare for professionals, knowledge of their patients, while patients, too, feel a lift in their quality of life. The app provides to make a phone call, video chat allowing engagement with doctors for smart diagnosis and effective treatment consultations.

CLIRNet with the help of advanced technology has taken arduous steps to bridge the gap between doctor peers. Doctors from different parts of India with different specialties and doctors who are not specialized can access the app for a quick solution to complex cases.